The Journal of Immunology, Vol 138, Issue 3 861-867, Copyright © 1987 by American Association of Immunologists

ARTICLES

Human skin mast cells: their dispersion, purification, and secretory characterization

RC Benyon, MA Lowman and MK Church

Digestion of human foreskin with collagenase and hyaluronidase disperses approximately 3.4 X 10(7) nucleated cells per gram of tissue, of which mast cells constitute 4.7%. These may be purified to 80% by use of density gradient centrifugation. The majority of mast cells (79%) measured between 9 and 13 micron in diameter, and the mean histamine content was 4.6 pg/cell. Viability was demonstrated by trypan blue exclusion by 93% of the cells and the low spontaneous histamine secretion of less than 7% in functional studies. Anti-IgE released up to 17.5% of cell-associated histamine within 5 to 7 min. Calcium ionophore-induced release was optimal with 0.3 microM A23187 when 28.6% histamine was released. Unlike human lung mast cells, skin mast cells released histamine in response to compound 48/80 and poly-L-lysine. This release, which was complete within 20 sec, was totally dependent on intact glycolysis and oxidative phosphorylation and partially dependent on extracellular calcium. The same characteristics were observed with secretion induced by substance P and morphine. The weak activity of eledoisin and physalaemin suggests that the substance P receptor, like that of the rat mast cell, is not of the classical types described for smooth muscle. Morphine-induced secretion was partially blocked by naloxone in a manner not compatible with competitive antagonism at a classical opioid receptor. The sensitivity of skin mast cells to nonimmunologic stimulation clearly distinguishes them from mast cells of the lung and lymphoid tissues and provides evidence of functional heterogeneity within human mast cells.

This article has been cited by other articles:

				F. Schiemann, T. A. Grimm, J. Hoch, R. Gross, B. Lindner, F. Petersen, S. Bulfone-Paus, and E. Brandt Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G Blood, March 15, 2006; 107(6): 2234 - 2242. [Abstract] [Full Text] [PDF]

				T. Fujimoto, T. Nishiyama, and K. Hanaoka Inhibitory Effects of Intravenous Anesthetics on Mast Cell Function Anesth. Analg., October 1, 2005; 101(4): 1054 - 1059. [Abstract] [Full Text] [PDF]

				R. Crompton, V. L. Clifton, A. T. Bisits, M. A. Read, R. Smith, and I. M. R. Wright Corticotropin-Releasing Hormone Causes Vasodilation in Human Skin via Mast Cell-Dependent Pathways J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5427 - 5432. [Abstract] [Full Text] [PDF]

				N. Kambe, M. Kambe, J. P. Kochan, and L. B. Schwartz Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes Blood, April 1, 2001; 97(7): 2045 - 2052. [Abstract] [Full Text] [PDF]

				J I McGILL, S T HOLGATE, M K CHURCH, D F ANDERSON, and A BACON Allergic eye disease mechanisms Br. J. Ophthalmol., October 1, 1998; 82(10): 1203 - 1214. [Full Text]

				S. He, M. D. A. Gaça, and A. F. Walls A Role for Tryptase in the Activation of Human Mast Cells: Modulation of Histamine Release by Tryptase and Inhibitors of Tryptase J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 289 - 297. [Abstract] [Full Text]

				K. Hartmann, B. M. Henz, S. Kruger-Krasagakes, J. Kohl, R. Burger, S. Guhl, I. Haase, U. Lippert, and T. Zuberbier C3a and C5a Stimulate Chemotaxis of Human Mast Cells Blood, April 15, 1997; 89(8): 2863 - 2870. [Abstract] [Full Text] [PDF]